BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26489159)

  • 1. [DISSEMINATED NONTUBERCULOUS MYCOBACTERIOSIS THAT IS POSITIVE FOR NEUTRALIZING ANTI-INTERFERON-GAMMA AUTOANTIBODIES: A NEW DISEASE CONCEPT BASED ON HOST FACTORS].
    Sakagami T
    Kekkaku; 2015 Jun; 90(6):561-4. PubMed ID: 26489159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
    Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
    J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
    Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
    BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
    Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
    BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
    Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
    PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
    Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
    BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome.
    Hirayama K; Kanda N; Suzuki T; Sasaki K; Kimura Y; Takahashi K; Matsumura M; Hatakeyama S
    J Infect Chemother; 2022 Sep; 28(9):1336-1339. PubMed ID: 35691862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
    Yeh YK; Ding JY; Ku CL; Chen WC
    BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
    Tanimizu M; Mizuno K; Hashimoto M
    Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
    King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
    J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
    Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
    Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
    Roerden M; Döffinger R; Barcenas-Morales G; Forchhammer S; Döbele S; Berg CP
    BMC Infect Dis; 2020 Nov; 20(1):828. PubMed ID: 33176707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
    Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
    Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
    Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
    Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.